Binding Database

BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

14 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID

Cmpds

Data

Article Title

Organization

51

Novel arylalkenylpropargylamines as neuroprotective, potent, and selective monoamine oxidase B inhibitors for the treatment of Parkinson's disease.

A*Star

50

Update on the Development of MNK Inhibitors as Therapeutic Agents.

A*Star

16

Novel Halomethylketone Azadipeptides for Treating COVID-19.

A*Star

42

Design, Synthesis, and Preclinical Evaluation of Fused Pyrimidine-Based Hydroxamates for the Treatment of Hepatocellular Carcinoma.

A*Star

56

Stepwise Evolution of Fragment Hits against MAPK Interacting Kinases 1 and 2.

A*Star

1

Substrate-based peptidomimetic inhibitors of the Murray Valley encephalitis virus NS2B/NS3 serine protease: a P1-P4 SAR study.

A*Star

52

Fragment-Based Drug Discovery of Potent Protein Kinase C Iota Inhibitors.

A*Star

26

Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia.

A*Star

13

BIPHENYL COMPOUND AS IMMUNOMODULATOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

Shenzhen Chipscreen Biosciences

287

Heterobicyclic amides as inhibitors of CD38

Ribon Therapeutics

9

Aminopyrazoles as selective janus kinase inhibitors

Intervet

31

Methods of treatment using pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds

Array Biopharma

6

Biotransformation of dehydroepiandrosterone with Macrophomina phaseolina and ß-glucuronidase inhibitory activity of transformed products.

University of Karachi

32

Potent acetylcholinesterase inhibitors: design, synthesis, and structure-activity relationships of bis-interacting ligands in the galanthamine series.

Cnrs